Search details
1.
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
Lancet
; 399(10330): 1141-1153, 2022 03 19.
Article
in English
| MEDLINE | ID: mdl-35305740
2.
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
PLoS Med
; 19(6): e1004024, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35727802
3.
Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa.
Vaccine
; 42(6): 1195-1199, 2024 Feb 27.
Article
in English
| MEDLINE | ID: mdl-38278629
4.
Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study).
BMJ Med
; 2(1): e000302, 2023.
Article
in English
| MEDLINE | ID: mdl-37063238
Results
1 -
4
de 4
1
Next >
>>